Home › Funds › Sofinnova Investments, Inc. › SVRA

Sofinnova Investments, Inc. position in SVRA

Savara Inc · Health Care

Sofinnova Investments, Inc. reported holding 364,763 shares of SVRA (Savara Inc) in its Q2 2026 13F filing — a position valued at US$2.2M, representing 0.12% of its reported portfolio and ranking #45 among its reported holdings. Sofinnova Investments, Inc. has disclosed SVRA holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)364.76K sh
Reported value held$2.25M
Portfolio Weight0.12%
First reportedQ3 2023
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Sofinnova Investments, Inc.'s SVRA position evolved

Sofinnova Investments, Inc. first disclosed a stake in SVRA in Q3 2023 at 157,908 shares (US$597K). The position peaked in Q3 2024 at 5,662,550 shares, worth US$24.0M. Across 12 filings, Sofinnova Investments, Inc. increased the stake 3 time(s), trimmed it 6 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 364,763 shares valued at US$2.2M. Notable position changes include a 1409% increase in Q4 2023 (shares rose 6% over the following quarter), a 94% trim in Q2 2024 (shares rose 5% over the following quarter), a 3675% increase in Q3 2024 (shares fell 28% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 157.91K $596.89K New
Q4 2023 2.38M $11.20M Add
Q1 2024 2.35M $11.69M Reduce
Q2 2024 150.00K $604.50K Reduce
Q3 2024 5.66M $24.01M Add
Q4 2024 5.47M $16.80M Reduce
Q1 2025 5.48M $15.18M Hold
Q2 2025 2.46M $5.60M Reduce
Q3 2025 2.43M $8.67M Reduce
Q4 2025 304.77K $1.84M Reduce
Q1 2026 364.76K $1.99M Add
Q2 2026 364.76K $2.25M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About SVRA and 13F data

SVRA (Savara Inc) is a Health Care company. 45 other funds we track also report a position in SVRA — the largest reported positions include NEA Management Company, LLC (US$150.7M), Bain Capital Life Sciences Investors, LLC (US$108.4M), Venrock Adviser, LLC (US$90.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding SVRA

All SVRA fund holders →

FAQ

How long has Sofinnova Investments, Inc. held SVRA?

Sofinnova Investments, Inc. has disclosed SVRA holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Sofinnova Investments, Inc.'s current position in SVRA?

As of Q2 2026, Sofinnova Investments, Inc. holds 364.76K shares of SVRA (Savara Inc), valued at $2.25M, representing 0.12% of its reported portfolio and ranking #45.

Has Sofinnova Investments, Inc. been buying or selling SVRA?

In the latest 13F filing (Q2 2026), Sofinnova Investments, Inc. held unchanged its position in SVRA. The position peaked in Q3 2024 at 5.66M shares.

Which other funds hold SVRA?

Other major institutional holders of SVRA include NEA Management Company, LLC, Bain Capital Life Sciences Investors, LLC, Venrock Adviser, LLC, among 45 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.